Insider · CIK 0001831519

Kayitalire Louis

Reports to the SEC for 1 company · CAMBRIDGE, X0

sec.gov

Transactions

Companies

Filings

CIK

0001831519

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-03-08	F-star Therapeutics, Inc.U Disposition from Tender	CHIEF MEDICAL OFFICER	UDisposition from Tender	−29.2K sh	$7.12	−$208K	25,019
2023-03-08	F-star Therapeutics, Inc.D Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−25K sh	$7.12	−$178K	0
2023-03-08	F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−27.3K sh	—	—	0
2023-03-08	F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−12.9K sh	—	—	0
2023-03-08	F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−53.6K sh	—	—	0
2023-03-08	F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−35.7K sh	—	—	0
2022-03-31	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	CHIEF MEDICAL OFFICER	AAward	+35.7K sh	—	—	35,719
2022-01-09	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	CHIEF MEDICAL OFFICER	AAward	+53.6K sh	—	—	53,634
2021-11-02	F-star Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−39 sh	$6.81	−$265.59	54,280
2021-11-02	F-star Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−25 sh	$6.85	−$171.25	54,255
2021-10-04	F-star Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−64 sh	$7.23	−$462.438	54,319
2021-07-02	F-star Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−1,054 sh	$8.43	−$8,885.22	54,383
2021-03-09	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	CHIEF MEDICAL OFFICER	AAward	+12.9K sh	—	—	40,169
2021-02-01	F-star Therapeutics, Inc.A Award	CHIEF MEDICAL OFFICER	AAward	+29K sh	—	—	55,437
2020-11-20	F-star Therapeutics, Inc.A Award	CHIEF MEDICAL OFFICER	AAward	+26.4K sh	—	—	26,437
2020-11-20	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	CHIEF MEDICAL OFFICER	AAward	+27.3K sh	—	—	27,289
2020-11-20	F-star Therapeutics, Inc.Restricted Stock UnitsA Award	CHIEF MEDICAL OFFICER	AAward	+26.4K sh	—	—	26,437

Recent filings

Accepted (ET)
Mar 94
Kayitalire Louis0000899243-23-007670
SEC(opens sec.gov)
Apr 44
Kayitalire Louis0001209191-22-022302
SEC(opens sec.gov)
Jan 114
Kayitalire Louis0001209191-22-002921
SEC(opens sec.gov)
Nov 44
Kayitalire Louis0001209191-21-063046
SEC(opens sec.gov)
Oct 64
Kayitalire Louis0001209191-21-059842
SEC(opens sec.gov)
Aug 244/A
Kayitalire Louis0001209191-21-053224
SEC(opens sec.gov)
Jul 74
Kayitalire Louis0001209191-21-045957
SEC(opens sec.gov)
Mar 114
Kayitalire Louis0001209191-21-019766
SEC(opens sec.gov)
Feb 24
Kayitalire Louis0001209191-21-006764
SEC(opens sec.gov)
Nov 244
Kayitalire Louis0001209191-20-060362
SEC(opens sec.gov)

Companies

F-star Therapeutics, Inc.CHIEF MEDICAL OFFICER

Address

C/O F-STAR THERAPEUTICS, INC. EDDEVA B920, BABRAHAM RESEARCH CAMPUS

CAMBRIDGE, X0, CB22 3AT